Biggest News Aggregation in the World
📰 Recurrence Score News

Page 2 - Recurrence Score News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Recurrence Score. Real-time updates on events, politics, business and more.

Addition of Ribociclib to Endocrine Therapy Provides iDFS Benefit in HR+/HER2– Early Breast Cancer

Treatment with ribociclib plus endocrine therapy led to a statistically and clinically meaningful improvement in invasive disease-free survival among patients with hormone receptor–positive/HER2-negative early breast cancer compared with endocrine therapy alone, meeting the primary end point of the phase 3 NATALEE trial.
University Of Chicago United States Rita Nanda Los Angeles Dennisj Slamon University Of Chicago Medicine

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science